0
Home
News
Directory
E-newsletter
Magazine
Events
Data
AgReport
Subscribe
Stockton’s Timorex Gold registered in China
Jan. 10, 2017
STK
IsraelFollow
IsraelRelated News
- Stockton enters into a long-term distribution agreement with Chongqing Shurong Crop Science Ltd. for Timorex Gold® in China
- Stockton receives registration of biofungicide Timorex Gold® in New Zealand
- Stockton foresees a promising future in Brazil with Timorex Gold®
- Stockton’s Timorex Gold now registered in 30 states in the USA
- Stockton to introduce its Timorex Gold biofungicide in US market
Stockton has pioneered plant extract biopesticides with its flagship biofungicide, Timorex Gold, used in conventional spraying programs for sustainable crop production. In China, Timorex Gold presents a true alternative for the tomato and strawberry producers, as this natural fungicide enables chemical load reduction and is a highly effective resistance management tool. Timorex Gold not only showed equal control of most diseases on many crops when joint spray program with conventional fungicides also can improve quality of fruits and vegetables.
“China approval is an important milestone for Timorex Gold. We project a big future in this market,” stated Guy Elitzur, CEO of Stockton. “This is a significant confirmation of our product’s platform, paving the way for the flow of our new and innovative products and for sustainable crop protection.”
Agriculture is a vital industry in China, employing over 300 million farmers and the second-largest economy in the world, growing rapidly, around 26% shares, in the Asia-Pacific biopesticides market. Timorex Gold registration approval in China will be a very helpful tool to support Chinese government agenda to reduce chemical pesticide and chemical fertilizer application policy.
“Our registration in China is extremely important for our Timorex Gold. We anticipate a great commercial future for our product in this significant market,” concluded Guy Elitzur.
Source: Stockton news release
More from AgroNews
Change
Hot TopicSubscribe
| Subscribe Email: | * | |
| Name: | ||
| Mobile Number: | ||
Comment
0/1200
NEWSLETTER